- Home
- CCM vs BIVI Comparison
CCM vs BIVI Comparison
Compare CCM & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- BIVI
- Stock Information
- Founded
- CCM 1997
- BIVI 2013
- Country
- CCM China
- BIVI United States
- Employees
- CCM N/A
- BIVI N/A
- Industry
- CCM Medical/Nursing Services
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- BIVI Health Care
- Exchange
- CCM Nasdaq
- BIVI Nasdaq
- Market Cap
- CCM 18.2M
- BIVI 18.8M
- IPO Year
- CCM 2009
- BIVI N/A
- Fundamental
- Price
- CCM $4.73
- BIVI $0.84
- Analyst Decision
- CCM
- BIVI Strong Buy
- Analyst Count
- CCM 0
- BIVI 1
- Target Price
- CCM N/A
- BIVI $30.00
- AVG Volume (30 Days)
- CCM 29.8K
- BIVI 204.2K
- Earning Date
- CCM 05-02-2025
- BIVI 05-13-2025
- Dividend Yield
- CCM N/A
- BIVI N/A
- EPS Growth
- CCM N/A
- BIVI N/A
- EPS
- CCM N/A
- BIVI N/A
- Revenue
- CCM $64,910,622.00
- BIVI N/A
- Revenue This Year
- CCM N/A
- BIVI N/A
- Revenue Next Year
- CCM N/A
- BIVI N/A
- P/E Ratio
- CCM N/A
- BIVI N/A
- Revenue Growth
- CCM N/A
- BIVI N/A
- 52 Week Low
- CCM $3.80
- BIVI $0.62
- 52 Week High
- CCM $26.70
- BIVI $7.50
- Technical
- Relative Strength Index (RSI)
- CCM 58.04
- BIVI 43.29
- Support Level
- CCM $3.88
- BIVI $0.75
- Resistance Level
- CCM $4.55
- BIVI $0.89
- Average True Range (ATR)
- CCM 0.39
- BIVI 0.12
- MACD
- CCM 0.07
- BIVI 0.02
- Stochastic Oscillator
- CCM 84.16
- BIVI 64.96
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.